Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$913M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 3 |
Microsoft
MSFT
|
+$369M |
| 4 |
MongoDB
MDB
|
+$345M |
| 5 |
Grab
GRAB
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$867M |
| 2 |
PayPal
PYPL
|
+$519M |
| 3 |
Alibaba
BABA
|
+$393M |
| 4 |
CrowdStrike
CRWD
|
+$360M |
| 5 |
DOCU
DocuSign
DOCU
|
+$335M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.56% |
| 2 | Healthcare | 12.66% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Televisa
TV
$1.52B
| $187K | ﹤0.01% |
+20,001
| New | +$205K |
|
|
KLRS
3702
Kalaris Therapeutics
KLRS
$93.7M
| $187K | ﹤0.01% |
631
-81
| -11% | -$37.6K |
|
|
HZN
3703
DELISTED
Horizon Global Corporation
HZN
| $187K | ﹤0.01% |
23,484
-1,518
| -6% | -$11.4K |
|
|
KRON
3704
DELISTED
Kronos Bio
KRON
| $186K | ﹤0.01% |
13,688
-171
| -1% | -$2.67K |
|
3705
Oramed Pharmaceuticals
ORMP
$175M
| $186K | ﹤0.01% |
12,991
-742,204
| -98% | -$15.5M |
|
|
AIFU
3706
AIFU Inc
AIFU
$220M
| $186K | ﹤0.01% |
64
+6
| +10% | +$28.8K |
|
|
ACOR
3707
DELISTED
Acorda Therapeutics
ACOR
| $186K | ﹤0.01% |
3,893
-253
| -6% | -$17.4K |
|
|
MRSN
3708
DELISTED
Mersana Therapeutics
MRSN
| $185K | ﹤0.01% |
1,189
-99
| -8% | -$19.3K |
|
|
IDEX
3709
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $185K | ﹤0.01% |
1,226
-126
| -9% | -$26.9K |
|
|
DS
3710
DELISTED
Drive Shack Inc.
DS
| $183K | ﹤0.01% |
127,668
-8,475
| -6% | -$18.7K |
|
3711
PolyPid
PYPD
$91.5M
| $182K | ﹤0.01% |
1,055
+352
| +50% | +$74.3K |
|
3712
Cullinan Oncology
CGEM
$1.18B
| $180K | ﹤0.01% |
11,631
+2,504
| +27% | +$49.9K |
|
|
KDNY
3713
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $180K | ﹤0.01% |
11,047
-945
| -8% | -$13.5K |
|
|
ALLK
3714
DELISTED
Allakos
ALLK
| $179K | ﹤0.01% |
18,237
-54,769
| -75% | -$4.49M |
|
3715
Cemex
CX
$16.3B
| $177K | ﹤0.01% |
26,001
-164,927
| -86% | -$1.07M |
|
3716
Curis
CRIS
$7.13M
| $176K | ﹤0.01% |
92
-34
| -27% | -$80.9K |
|
3717
Oric Pharmaceuticals
ORIC
$1.41B
| $176K | ﹤0.01% |
12,010
-1,516
| -11% | -$23.6K |
|
3718
Omeros
OMER
$986M
| $173K | ﹤0.01% |
26,895
-2,111
| -7% | -$15.3K |
|
|
FONR
3719
DELISTED
Fonar
FONR
| $171K | ﹤0.01% |
11,440
-743
| -6% | -$11.9K |
|
|
XXII
3720
22nd Century Group
XXII
$1.5M
| – | – |
0
| – | – |
|
|
ALR
3721
DELISTED
AlerisLife Inc
ALR
| $170K | ﹤0.01% |
57,540
-3,724
| -6% | -$13.5K |
|
|
FMTX
3722
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $170K | ﹤0.01% |
11,933
-1,957
| -14% | -$33.9K |
|
3723
Caledonia Mining Corp
CMCL
$439M
| $168K | ﹤0.01% |
14,407
-935
| -6% | -$11.7K |
|
3724
Precision BioSciences
DTIL
$206M
| $168K | ﹤0.01% |
758
-48
| -6% | -$13.4K |
|
3725
Erasca
ERAS
$6.29B
| $167K | ﹤0.01% |
+10,747
| New | +$184K |
|
Similar funds
Invesco's Q4 2021 Portfolio in Review
As of Q4 2021, Invesco held 4,196 positions worth $415B, up 5.1% from $395B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Invesco's Q4 2021 filing shows 190 new, 1,645 increased, 2,044 reduced and 170 closed positions. Its largest new stake was Grab: 44,484,753 shares worth $317M. The largest sale was Meta Platforms (Facebook), an estimated $867M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q4 2021 buy was Grab: 44,484,753 shares worth $317M.
- Invesco added most to Apple in Q4 2021, an estimated $913M increase.
- Invesco's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $867M.
- Invesco fully exited Kansas City Southern in Q4 2021, selling an estimated $110M.
- Invesco's ten largest holdings make up 12% of its $415B portfolio in Q4 2021.
- Invesco opened 190 new positions and closed 170 in Q4 2021.
- Invesco's portfolio value rose 5.1% quarter-over-quarter to $415B.
Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.